Literature DB >> 17189190

Structure of the papillomavirus DNA-tethering complex E2:Brd4 and a peptide that ablates HPV chromosomal association.

Eric A Abbate1, Christian Voitenleitner, Michael R Botchan.   

Abstract

Many DNA viruses that are latent in dividing cells are noncovalent passengers on mitotic chromosomes and require specific viral-encoded and cellular factors for this activity. The chromosomal protein Brd4 is implicated in the hitchhiking of bovine papillomavirus-1 (BPV-1), and the viral protein E2 binds to both plasmids and Brd4. Here, we present the X-ray crystal structure of the carboxy-terminal domain of Brd4 in complex with HPV-16 E2, and with this information have developed a Brd4-Tat fusion protein that is efficiently taken up by different transformed cells harboring HPV plasmids. In cells treated with these fusion proteins for only 2 hr and arrested in metaphase, the HPV DNA, either HPV-16 or -31, is displaced from mitotic chromosomes. Mutant Brd4 peptides are deficient in ablating this association. We suggest that such peptides may lead to the development of inhibitors of latency for many, if not all, papillomaviruses.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17189190     DOI: 10.1016/j.molcel.2006.11.002

Source DB:  PubMed          Journal:  Mol Cell        ISSN: 1097-2765            Impact factor:   17.970


  68 in total

Review 1.  The latency-associated nuclear antigen, a multifunctional protein central to Kaposi's sarcoma-associated herpesvirus latency.

Authors:  Mary E Ballestas; Kenneth M Kaye
Journal:  Future Microbiol       Date:  2011-12       Impact factor: 3.165

2.  Phosphorylation of the Human Papillomavirus E2 Protein at Tyrosine 138 Regulates Episomal Replication.

Authors:  Leny Jose; Elliot J Androphy; Marsha DeSmet
Journal:  J Virol       Date:  2020-07-01       Impact factor: 5.103

3.  Brd4-independent transcriptional repression function of the papillomavirus e2 proteins.

Authors:  Michal-Ruth Schweiger; Matthias Ottinger; Jianxin You; Peter M Howley
Journal:  J Virol       Date:  2007-07-11       Impact factor: 5.103

Review 4.  Replication and partitioning of papillomavirus genomes.

Authors:  Alison A McBride
Journal:  Adv Virus Res       Date:  2008       Impact factor: 9.937

5.  The interaction of the gammaherpesvirus 68 orf73 protein with cellular BET proteins affects the activation of cell cycle promoters.

Authors:  Matthias Ottinger; Daniel Pliquet; Thomas Christalla; Ronald Frank; James P Stewart; Thomas F Schulz
Journal:  J Virol       Date:  2009-02-25       Impact factor: 5.103

6.  Papillomavirus E2 protein is regulated by specific fibroblast growth factor receptors.

Authors:  Marsha DeSmet; Sriramana Kanginakudru; Leny Jose; Fang Xie; Timra Gilson; Elliot J Androphy
Journal:  Virology       Date:  2018-06-06       Impact factor: 3.616

7.  Solution structure of the extraterminal domain of the bromodomain-containing protein BRD4.

Authors:  Yi-Jan Lin; Takashi Umehara; Makoto Inoue; Kohei Saito; Takanori Kigawa; Moon-Kyoo Jang; Keiko Ozato; Shigeyuki Yokoyama; Balasundaram Padmanabhan; Peter Güntert
Journal:  Protein Sci       Date:  2008-09-24       Impact factor: 6.725

8.  Genetic analysis of the E2 transactivation domain dimerization interface from bovine papillomavirus type 1.

Authors:  David Gagnon; Hélène Sénéchal; Claudia M D'Abramo; Jennifer Alvarez; Alison A McBride; Jacques Archambault
Journal:  Virology       Date:  2013-03-11       Impact factor: 3.616

Review 9.  Involvement of Brd4 in different steps of the papillomavirus life cycle.

Authors:  Thomas Iftner; Juliane Haedicke-Jarboui; Shwu-Yuan Wu; Cheng-Ming Chiang
Journal:  Virus Res       Date:  2016-12-10       Impact factor: 3.303

10.  Cell-type specific transcriptional activities among different papillomavirus long control regions and their regulation by E2.

Authors:  Matthias Ottinger; Jennifer A Smith; Michal-Ruth Schweiger; Dana Robbins; Maria L C Powell; Jianxin You; Peter M Howley
Journal:  Virology       Date:  2009-12-20       Impact factor: 3.616

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.